You are here:

zonisamide (Zonegran)

Advice

in the absence of a submission from the holder of the marketing authorisation:

zonisamide (Zonegran®) is not recommended for use within NHS Scotland.

Indication under review: monotherapy for the treatment of partial seizures (with or without secondary generalization) in adults with newly diagnosed epilepsy.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.
 

Drug Details

Drug Name: zonisamide (Zonegran)
SMC Drug ID: 817/12
Manufacturer: Eisai Ltd
Indication: monotherapy for the treatment of partial seizures (with or without secondary generalization) in adults with newly diagnosed epilepsy.
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 8 October 2012

Back